Dewen Mao
Impact in
-
- Liver Disease and Transplantation
-
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
- Epidemiology 11
- Liver Disease Diagnosis and Treatment 9
- Hepatitis B Virus Studies 2
-
- Gut microbiota and health 2
- Co-authors
- Hua Qiu (8 shared papers)Rongzhen Zhang (10 shared papers)Hanmin Li (2 shared papers)Na Wang (7 shared papers)Fang Xie (1 shared paper)Xiaodan Li (1 shared paper)Xianbo Wang (3 shared papers)Qianqian Zhang (2 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (5 papers)Scientific Reports (2 papers)Journal of Biomedical Nanotechnology (1 paper)Journal of Pharmaceutical and Biomedical Analysis (1 paper)Phytomedicine (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Dewen Mao
23 papers receiving 188 citations
Peers
Comparison fields: 5 of 47
- Hepatology 45
- Pharmacology 30
- Complementary and alternative medicine 24
- Epidemiology 47
- Cancer Research 11
Countries citing papers authored by Dewen Mao
This map shows the geographic impact of Dewen Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewen Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewen Mao more than expected).
Fields of papers citing papers by Dewen Mao
This network shows the impact of papers produced by Dewen Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewen Mao. The network helps show where Dewen Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Dewen Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An experimental study on drugs for improving blood circulation and removing blood stasis in treating mild chronic hepatic damage. | 2001 | 34 |
| 2 | 2020 | 20 | |
| 3 | 2018 | 17 | |
| 4 | 2018 | 14 | |
| 5 | 2020 | 12 | |
| 6 | 2017 | 11 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2017 | 10 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 7 | |
| 12 | 2022 | 6 | |
| 13 | 2023 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2015 | 4 | |
| 19 | 2023 | 2 | |
| 20 | 2021 | 2 |
About Dewen Mao
Dewen Mao is a scholar working on Epidemiology, Molecular Biology, Pharmacology, Hepatology and Cancer Research, having authored 28 papers that have together received 196 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Liver Disease and Transplantation (5 papers), Hepatitis B Virus Studies (2 papers), Gut microbiota and health (2 papers), Immune cells in cancer (2 papers), Cancer Mechanisms and Therapy (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Hepatology (45 citations), Pharmacology (30 citations), Complementary and alternative medicine (24 citations), Epidemiology (47 citations) and Cancer Research (11 citations). Dewen Mao has collaborated with scholars based in China and South Korea. Frequent co-authors include Hua Qiu, Rongzhen Zhang, Hanmin Li, Na Wang, Fang Xie, Xiaodan Li, Xianbo Wang, Qianqian Zhang, Guoliang Chen and Lihong Liu. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Scientific Reports, Journal of Biomedical Nanotechnology, Journal of Pharmaceutical and Biomedical Analysis and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.